Page last updated: 2024-11-07

dehydroepiandrosterone and Carcinoma, Papillary

dehydroepiandrosterone has been researched along with Carcinoma, Papillary in 1 studies

Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.

Carcinoma, Papillary: A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, MH1
Moon, JY1
Cho, SH1
Chung, BC1
Lee, EJ1

Other Studies

1 other study available for dehydroepiandrosterone and Carcinoma, Papillary

ArticleYear
Metabolic alteration of urinary steroids in pre- and post-menopausal women, and men with papillary thyroid carcinoma.
    BMC cancer, 2011, Aug-08, Volume: 11

    Topics: Adult; Androstenediol; Androstenedione; Carcinoma, Papillary; Dehydroepiandrosterone; Estradiol; Est

2011